Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TGTX |
---|---|---|
09:32 ET | 23745 | 21.9902 |
09:34 ET | 3300 | 21.97 |
09:36 ET | 2220 | 22.09 |
09:38 ET | 7328 | 22.1596 |
09:39 ET | 9356 | 22.13 |
09:41 ET | 10272 | 22 |
09:43 ET | 6788 | 22.0718 |
09:45 ET | 2986 | 22.22 |
09:48 ET | 15269 | 22.275 |
09:50 ET | 3762 | 22.28 |
09:52 ET | 8986 | 22.28 |
09:54 ET | 2550 | 22.194 |
09:56 ET | 2191 | 22.1709 |
09:57 ET | 1617 | 22.32 |
09:59 ET | 2400 | 22.37 |
10:01 ET | 5177 | 22.4 |
10:03 ET | 10924 | 22.4 |
10:06 ET | 6631 | 22.37 |
10:08 ET | 6027 | 22.445 |
10:10 ET | 3300 | 22.37 |
10:12 ET | 10330 | 22.245 |
10:14 ET | 11201 | 22.27 |
10:15 ET | 6400 | 22.2698 |
10:17 ET | 3100 | 22.3 |
10:19 ET | 3300 | 22.29 |
10:21 ET | 11313 | 22.28 |
10:24 ET | 1600 | 22.28 |
10:26 ET | 3944 | 22.325 |
10:28 ET | 8298 | 22.295 |
10:30 ET | 1524 | 22.29 |
10:32 ET | 4034 | 22.19 |
10:33 ET | 6525 | 22.24 |
10:35 ET | 4200 | 22.195 |
10:37 ET | 16820 | 22.13 |
10:39 ET | 33291 | 21.95 |
10:42 ET | 11905 | 21.9 |
10:44 ET | 11740 | 21.78 |
10:46 ET | 22974 | 21.8234 |
10:48 ET | 17364 | 21.74 |
10:50 ET | 14453 | 21.84 |
10:51 ET | 10598 | 21.82 |
10:53 ET | 30308 | 21.95 |
10:55 ET | 8954 | 21.975 |
10:57 ET | 400 | 21.97 |
11:00 ET | 10414 | 21.9 |
11:02 ET | 5669 | 21.88 |
11:04 ET | 5762 | 21.85 |
11:06 ET | 6545 | 21.88 |
11:08 ET | 4100 | 21.79 |
11:09 ET | 6542 | 21.77 |
11:11 ET | 8462 | 21.72 |
11:13 ET | 21806 | 21.69 |
11:15 ET | 20257 | 21.67 |
11:18 ET | 27481 | 21.585 |
11:20 ET | 136864 | 21.565 |
11:22 ET | 31331 | 21.4801 |
11:24 ET | 5109 | 21.505 |
11:26 ET | 6830 | 21.535 |
11:27 ET | 17994 | 21.38 |
11:29 ET | 15629 | 21.38 |
11:31 ET | 11715 | 21.33 |
11:33 ET | 23920 | 21.4027 |
11:36 ET | 10810 | 21.49 |
11:38 ET | 21679 | 21.5566 |
11:40 ET | 6035 | 21.49 |
11:42 ET | 4351 | 21.45 |
11:44 ET | 12505 | 21.52 |
11:45 ET | 2884 | 21.5099 |
11:47 ET | 10030 | 21.42 |
11:49 ET | 2200 | 21.41 |
11:51 ET | 24680 | 21.39 |
11:54 ET | 6625 | 21.37 |
11:56 ET | 3374 | 21.375 |
11:58 ET | 2561 | 21.32 |
12:00 ET | 6954 | 21.33 |
12:02 ET | 9663 | 21.32 |
12:03 ET | 8164 | 21.31 |
12:05 ET | 8290 | 21.28 |
12:07 ET | 26578 | 21.32 |
12:09 ET | 13558 | 21.38 |
12:12 ET | 5537 | 21.39 |
12:14 ET | 8918 | 21.38 |
12:16 ET | 5918 | 21.39 |
12:18 ET | 9576 | 21.31 |
12:20 ET | 1400 | 21.3 |
12:21 ET | 9864 | 21.39 |
12:23 ET | 6965 | 21.29 |
12:25 ET | 9403 | 21.29 |
12:27 ET | 8845 | 21.3199 |
12:30 ET | 5635 | 21.35 |
12:32 ET | 4754 | 21.48 |
12:34 ET | 10289 | 21.5142 |
12:36 ET | 15602 | 21.42 |
12:38 ET | 3732 | 21.38 |
12:39 ET | 9717 | 21.44 |
12:41 ET | 6155 | 21.43 |
12:43 ET | 1433 | 21.41 |
12:45 ET | 4681 | 21.44 |
12:48 ET | 3676 | 21.45 |
12:50 ET | 9008 | 21.498 |
12:52 ET | 2860 | 21.505 |
12:54 ET | 6110 | 21.46 |
12:56 ET | 7967 | 21.4493 |
12:57 ET | 3469 | 21.48 |
12:59 ET | 13338 | 21.445 |
01:01 ET | 11427 | 21.45 |
01:03 ET | 15546 | 21.46 |
01:06 ET | 6033 | 21.43 |
01:08 ET | 8631 | 21.395 |
01:10 ET | 11736 | 21.375 |
01:12 ET | 5506 | 21.43 |
01:14 ET | 7769 | 21.39 |
01:15 ET | 4669 | 21.37 |
01:17 ET | 1875 | 21.38 |
01:19 ET | 4991 | 21.36 |
01:21 ET | 1845 | 21.3699 |
01:24 ET | 2239 | 21.3799 |
01:26 ET | 4548 | 21.315 |
01:28 ET | 8616 | 21.34 |
01:30 ET | 6866 | 21.35 |
01:32 ET | 5194 | 21.355 |
01:33 ET | 7649 | 21.31 |
01:35 ET | 13106 | 21.33 |
01:37 ET | 7410 | 21.38 |
01:39 ET | 2300 | 21.33 |
01:42 ET | 2876 | 21.31 |
01:44 ET | 1500 | 21.3 |
01:46 ET | 2946 | 21.325 |
01:48 ET | 3749 | 21.34 |
01:50 ET | 5823 | 21.36 |
01:51 ET | 4695 | 21.31 |
01:53 ET | 4300 | 21.32 |
01:55 ET | 10529 | 21.29 |
01:57 ET | 7017 | 21.2826 |
02:00 ET | 9732 | 21.3 |
02:02 ET | 3145 | 21.29 |
02:04 ET | 4020 | 21.23 |
02:06 ET | 2856 | 21.26 |
02:08 ET | 2014 | 21.23 |
02:09 ET | 11426 | 21.275 |
02:11 ET | 5346 | 21.19 |
02:13 ET | 3347 | 21.16 |
02:15 ET | 6028 | 21.21 |
02:18 ET | 11184 | 21.17 |
02:20 ET | 3863 | 21.165 |
02:22 ET | 6516 | 21.17 |
02:24 ET | 3866 | 21.19 |
02:26 ET | 3379 | 21.215 |
02:27 ET | 6050 | 21.1803 |
02:29 ET | 10584 | 21.15 |
02:31 ET | 3810 | 21.16 |
02:33 ET | 6537 | 21.14 |
02:36 ET | 7395 | 21.11 |
02:38 ET | 5767 | 21.115 |
02:40 ET | 3590 | 21.095 |
02:42 ET | 8999 | 21.09 |
02:44 ET | 16122 | 21.06 |
02:45 ET | 4496 | 21.065 |
02:47 ET | 48417 | 21.035 |
02:49 ET | 33231 | 21 |
02:51 ET | 7845 | 20.96 |
02:54 ET | 20758 | 20.91 |
02:56 ET | 15786 | 20.97 |
02:58 ET | 21211 | 20.99 |
03:00 ET | 3821 | 20.999 |
03:02 ET | 3183 | 21.02 |
03:03 ET | 1913 | 21.02 |
03:05 ET | 4645 | 20.98 |
03:07 ET | 8030 | 20.96 |
03:09 ET | 12260 | 20.9581 |
03:12 ET | 4295 | 20.9099 |
03:14 ET | 18973 | 20.93 |
03:16 ET | 5135 | 20.99 |
03:18 ET | 6710 | 21 |
03:20 ET | 3365 | 20.98 |
03:21 ET | 6205 | 20.96 |
03:23 ET | 10655 | 20.95 |
03:25 ET | 5782 | 20.98 |
03:27 ET | 3486 | 21.06 |
03:30 ET | 5569 | 21.05 |
03:32 ET | 6589 | 21.11 |
03:34 ET | 8231 | 21.13 |
03:36 ET | 4602 | 21.165 |
03:38 ET | 18448 | 21.22 |
03:39 ET | 14508 | 21.33 |
03:41 ET | 16013 | 21.24 |
03:43 ET | 7741 | 21.31 |
03:45 ET | 4307 | 21.3 |
03:48 ET | 11051 | 21.28 |
03:50 ET | 6881 | 21.3 |
03:52 ET | 17343 | 21.27 |
03:54 ET | 16183 | 21.22 |
03:56 ET | 22543 | 21.22 |
03:57 ET | 25512 | 21.23 |
03:59 ET | 44335 | 21.23 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
TG Therapeutics Inc | 3.4B | 96.3x | --- |
Arrowhead Pharmaceuticals Inc | 3.5B | -6.5x | --- |
Twist Bioscience Corp | 3.3B | -16.0x | --- |
ADMA Biologics Inc | 3.1B | -639.7x | --- |
MorphoSys AG | 2.8B | -5.4x | --- |
Denali Therapeutics Inc | 3.3B | -22.5x | --- |
TG Therapeutics, Inc. is a fully integrated, commercial stage, biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its clinical drug candidates include Ublituximab (anti-CD20 mAb), TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb). BRIUMVI is an anti-CD20 monoclonal antibody for the treatment of RMS, which include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TG-1701 is a novel, orally available and covalently bound Bruton’s tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in in vitro kinase screening. TG-1801 is a bispecific CD47 and CD19 antibody. It is the therapy to target both CD19, a B-cell specific market expressed across B-cell malignancies, and CD47. It also evaluates complementary products, technologies and companies for in-licensing, partnership, acquisition and/or investment opportunities.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.4B |
---|---|
Revenue (TTM) | $289.3M |
Shares Outstanding | 154.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.24 |
EPS | $0.22 |
Book Value | $1.06 |
P/E Ratio | 96.3x |
Price/Sales (TTM) | 11.8 |
Price/Cash Flow (TTM) | 82.5x |
Operating Margin | 16.71% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.